文献速递痛风与晶体性关节病

血浆代谢谱揭示痛风急性发作中5-脂氧合酶激活

Metabolic profiling of human plasma reveals the activation of 5-lipoxygenase in the acute attack of gouty arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究对痛风急性发作患者(n=26)与性别匹配健康对照(n=26)进行血浆多不饱和脂肪酸代谢谱分析,并在第二队列(每组n=20)中验证。结果发现两个队列中患者血浆白三烯B4(LTB4)均显著升高,归因于5-脂氧合酶激活与CYP4F3介导代谢之间的动态平衡;体外实验支持尿酸以剂量相关和时间依赖方式激活5-脂氧合酶和CYP4F3。

要点

  • 痛风急性发作患者血浆LTB4在发现队列和验证队列中均显著升高。
  • LTB4升高主要归因于5-脂氧合酶激活,CYP4F3参与其代谢平衡。
  • 抑制5-脂氧合酶可能具有临床治疗价值。

核心结论

  • 痛风急性发作患者血浆LTB4升高主要由于5-脂氧合酶激活。
  • 抑制5-脂氧合酶可能具有临床治疗价值。

研究设计与样本

  • 发现队列纳入痛风急性发作患者26例和性别匹配健康对照26例,进行血浆多不饱和脂肪酸代谢谱分析。
  • 验证队列每组20例,采用全血细胞和体外中性粒细胞研究相关机制。

主要发现

  • 两个队列中痛风急性发作患者血浆LTB4均显著升高。
  • 患者全血细胞中5-脂氧合酶和CYP4F3转录水平较对照显著升高。
  • 体外实验中尿酸在转录和分子水平以剂量相关和时间依赖方式激活5-脂氧合酶和CYP4F3。

临床怎么用

  • 血浆LTB4及5-脂氧合酶激活状态可能作为痛风急性发作的炎症监测指标。
  • 5-脂氧合酶抑制可能是痛风急性发作的潜在治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Monosodium urate-induced inflammation plays a vital role in acute gout (AG). Inflammation is a multi-stage process involved in the acute release of arachidonic acid and its metabolites. However, the function of the metabolism of arachidonic acid and other polyunsaturated fatty acids in AG is not well understood. This study aimed to investigate the modification of polyunsaturated fatty acid metabolism by AG. METHODS: Plasma samples from patients with an AG attack (n = 26) and gender-matched healthy controls (n = 26) were analysed by metabolic profiling of polyunsaturated fatty acids. The findings were further validated with a second cohort (n = 20 each group). The associated mechanisms were investigated in whole blood cells from the second cohort and neutrophils in vitro. RESULTS: Plasma metabolic profiling revealed a significant increase in leukotriene B4 (LTB4) for AG patients in both cohorts. The increase in plasma LTB4 was accounted for by the dynamic balance between the activation of 5-lipoxygenase and CYP4F3, the former mediating the biosynthesis of LTB4 and the latter mediating its metabolism. This was supported by significantly increased transcriptional levels of 5-lipoxygenase and CYP4F3 in whole blood cells from AG patients compared with those of controls, and the uric acid-caused dose-relevant and time-dependent activation of 5-lipoxygenase and CYP4F3 at the transcriptional and molecular levels in vitro. CONCLUSION: Increased LTB4 in AG patients is mainly due to activation of 5-lipoxygenase. 5-Lipoxygenase inhibition may be of therapeutic value clinically.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Luo Y, Wang L, Peng A, et al. Metabolic profiling of human plasma reveals the activation of 5-lipoxygenase in the acute attack of gouty arthritis. Rheumatology (Oxford). 2019. PMID: 30247644. doi:10.1093/rheumatology/key284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。